Therefore, instead of using biochemical phenotyping, in this study, we investigated the association between GS and HBV infection outcomes using UGT1A1 genotyping and explored the therapeutic potential of hyperbilirubinemia against HBV infection for the first time. The gene discussed is UGT1A1; the disease is Hyperbilirubinemia.